XML 165 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions (Details) - Schedule of Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Proteomedix [Member]    
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]    
Revenue $ 58,465  
Net loss 315,688  
PMX Transaction [Member]    
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]    
Revenue 2,601,310 $ 392,460
Net loss $ 38,577,046 $ 16,326,247